EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

15. How should clinics compare GLP-1 pharmacy quotes?

Dose Diligence research deskSection 01 · Page 15 of 34Last updated 17 Nov 2026

Require every bidder to quote the same scenario and identify who pays each charge. Reject an apparently comparable monthly price if the product, presentation, fill interval or eligibility differs.

Use this proposed quotation schedule:

FieldRequired answer
Product identityBrand or preparation, active ingredient, presentation, strength and pack size
RouteClinic inventory, patient dispensing or facilitated access
Clinical assumptionsClinic-supplied dose mix and duration; no supplier-generated treatment schedule
Medicine costIntroductory and continuing prices; eligibility conditions
DispensingSeparate charge or explicit inclusion
ShippingStandard, expedited, weekend, remote-area and replacement charges
LossesFailed delivery, damage, temperature excursion and non-refundable orders
TechnologyImplementation, subscription and transaction fees
CommitmentsMinimum volumes, deposits, exclusivity and personal guarantees
Price changesNotice period, programme expiry and pass-through mechanics
Payment responsibilityClinic, patient, insurer or another party

The need to distinguish timing and presentation is visible in manufacturer terms: Lilly defines relevant monthly supplies as 28 days, while Novo’s tablet offer uses a 30-tablet bottle. (zepbound.lilly.com)

Negotiation target: a signed pricing exhibit with no undefined all-inclusive line.

Explore the table row by row

A working view of the research

Product identity

Required answer
Brand or preparation, active ingredient, presentation, strength and pack size

Sources cited on this page

  1. zepbound.lilly.com · Source 1 ↗https://zepbound.lilly.com/hcp/coverage-savings
Section sources →